RVNC
Revance Therapeutics Inc
Price:  
2.92 
USD
Volume:  
1,917,280.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Probability of Bankruptcy

The Probability of Bankruptcy of Revance Therapeutics Inc (RVNC) is 76.25% . This number represents the probability that RVNC will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating RVNC's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

RVNC - ESG ratings

ESG ratings are directly linked to the cost of capital and RVNC's ability to raise funding, both of which can significantly affect the probability of Revance Therapeutics Inc going bankrupt.

ESG Score 23.36
Environment Score 18.62
Social Score 27.15
Governance Score 24.31
Returns
Historical Returns (5 day) -7.59%
Historical Returns (MTD) -19.11%
Historical Returns (YTD) -66.78%
Historical Returns (13 week) -45.62%
Historical Returns (26 week) -58.40%
Historical Returns (52 week) -90.72%
Efficiency
Asset Turnover 0.45
Receiveable Turnover 10.45
Gross Margin 71.29%
Operating Margin -90.16%
Pretax Margin -95.36%
Net Margin -102.34%
Return on Asset (ROA) -59.97
Return on Equity (ROE) -482.92
Return on Investments (ROI) -66.25
Price Metrics
Market Cap (M) 304.32
Enterprise Value (M)
52 Week High 33.09
52 Week Low 2.90
Beta 1.80
Average Volume (10 day) 1.29
Average Volume (3 month) 0.65
Price / Earnings (P/E)
Price / Sales (P/S) 1.35
Earnings
EPS -3.65
Revenue CAGR (5 year) 129.20%
Risk
Current Ratio 5.37
Quick Ratio 4.50